Dr. Christopher Mcelrath, MD

NPI: 1205497047
Total Payments
$10,818
2023 Payments
$10,694
Companies
4
Transactions
12

Payment Breakdown by Category

Other$10,000 (92.4%)
Food & Beverage$818.24 (7.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Grant $10,000 1 92.4%
Food and Beverage $818.24 11 7.6%

Top Paying Companies

Company Total Records Latest Year
Medtronic, Inc. $10,451 9 $0 (2023)
Merck Sharp & Dohme Corporation $124.33 1 $0 (2019)
SPR Therapeutics, Inc $122.49 1 $0 (2023)
Averitas Pharma Inc. $120.60 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $10,694 11 Medtronic, Inc. ($10,451)
2019 $124.33 1 Merck Sharp & Dohme Corporation ($124.33)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/20/2023 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $120.60 General
Category: PAIN MANAGEMENT
12/16/2023 Medtronic, Inc. VANTA ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $43.62 General
Category: Spinal Cord Neurostimulation
12/16/2023 Medtronic, Inc. VANTA ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $40.83 General
Category: Spinal Cord Neurostimulation
12/16/2023 Medtronic, Inc. VANTA ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $21.65 General
Category: Spinal Cord Neurostimulation
12/16/2023 Medtronic, Inc. VANTA ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $21.09 General
Category: Spinal Cord Neurostimulation
12/16/2023 Medtronic, Inc. VANTA ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $6.25 General
Category: Spinal Cord Neurostimulation
12/15/2023 Medtronic, Inc. VANTA ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $167.55 General
Category: Spinal Cord Neurostimulation
12/15/2023 Medtronic, Inc. VANTA ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $57.45 General
Category: Spinal Cord Neurostimulation
10/12/2023 Medtronic, Inc. SYNCHROMEDII (Device) Grant Cash or cash equivalent $10,000.00 General
Category: Drug Infusion Systems
09/23/2023 SPR Therapeutics, Inc SPRINT PNS System (Device) Food and Beverage Cash or cash equivalent $122.49 General
Category: Pain management
09/20/2023 Medtronic, Inc. INTELLIS ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $92.38 General
Category: Spinal Cord Neurostimulation
07/23/2019 Merck Sharp & Dohme Corporation BRIDION (Drug) Food and Beverage In-kind items and services $124.33 General
Category: NEUROSCIENCE

About Dr. Christopher Mcelrath, MD

Dr. Christopher Mcelrath, MD is a Anesthesiology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2019. The National Provider Identifier (NPI) number assigned to this provider is 1205497047.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Mcelrath, MD has received a total of $10,818 in payments from pharmaceutical and medical device companies, with $10,694 received in 2023. These payments were reported across 12 transactions from 4 companies. The most common payment nature is "Grant" ($10,000).

Practice Information

  • Specialty Anesthesiology
  • Other Specialties Anesthesiology
  • Location Dallas, TX
  • Active Since 06/24/2019
  • Last Updated 09/12/2024
  • Taxonomy Code 207L00000X
  • Entity Type Individual
  • NPI Number 1205497047

Products in Payments

  • SYNCHROMEDII (Device) $10,000
  • VANTA ADAPTIVESTIM (Device) $358.44
  • BRIDION (Drug) $124.33
  • SPRINT PNS System (Device) $122.49
  • QUTENZA (Drug) $120.60
  • INTELLIS ADAPTIVESTIM (Device) $92.38

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anesthesiology Doctors in Dallas